Stay updated on Long-acting hGH in GHD Children Clinical Trial
Sign up to get notified when there's something new on the Long-acting hGH in GHD Children Clinical Trial page.

Latest updates to the Long-acting hGH in GHD Children Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the completed growth hormone follow-up study is displayed instead of a 403 Forbidden page.SummaryDifference46%

- Check15 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH banner announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 error page, with its footer revision updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, replacing the usual study details. The change set removes and replaces multiple study documents, metadata, and related terms from the record.SummaryDifference17%

Stay in the know with updates to Long-acting hGH in GHD Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-acting hGH in GHD Children Clinical Trial page.